{'fraction_non_alphanumeric': 0.02002503128911139, 'fraction_numerical': 0.0037546933667083854, 'mean_word_length': 5.722689075630252, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Deciding on stimulant use for childhood ADHD: maintaining focus on the key questions.

Attention deficit hyperactivity disorder (ADHD) is one of the most commonly investigated psychiatric disorders of childhood, and stimulants are among the most scrutinized evidence-based treatments. Controversy persists, however, about whether stimulants are appropriate and to what extent they should be used to treat problems of inattention and hyperactivity in children. Although detailed protocols are available to guide assessment and treatment of ADHD (eg, Dulcan,1 American Academy of Pediatrics2), I argue there are 3 primary questions that can facilitate a decision about medication use for problems of inattention and hyperactivity and a clearer discourse on appropriate stimulant use for such problems.